Search
for
Sort by
Research 211–240 of 1000+
- Alopecia: managing the basics
- Polycystic Ovary Syndrome in Adolescents
- Testosterone and female sexuality: A skeptical view
- AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY, INC.
- Fluridil, a Rationally Designed Topical Agent for Androgenetic Alopecia
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Hair Disorders
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- Management OF Patients with Polycystic Ovary Syndrom
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Polycystic Ovary Syndrome
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Hirsutism and Hypertrichosis
- Hormonal changes and hair growth during treatment of hirsutism with cimetidine.
- Congenital adrenal hyperplasia with polycystic ovarian disease: A rare cause of hirsutism
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Treatment of hirsutism and acne in hyperandrogenism
- No. 350-Hirsutism: Evaluation and Treatment
- Hirsutism
- Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering
- Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
- Hypertrichosis Induced by Minoxidil: A Case of Systemic Absorption from Scalp Occlusion
- Recent Advances in Drug Development for Hair Loss
- Ellagic acid inhibits dihydrotestosterone-induced ferroptosis and promotes hair regeneration by activating the Wnt/β-catenin signaling pathway
- Millets as a dietary supplement for managing chemotherapy induced side effects
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak